Colorectal cancer
Conditions
Interventions
Ropivacaine transversus abdominis plane block group (control group R):Ropivacaine transversus abdominis plane block
Bupivacaine liposomal transversus abdominis plane block group (experimental group LB):Bupivacaine liposomal transversus abdominis plane block
Sponsors
Second Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Laparoscopic colorectal surgery under general anesthesia was performed; 2. Age: 18-75 years old; 3. BMI 18~28 kg/m^2; 4. No gender limitation; 5. Clear language and consciousness, able to cooperate with research; 6. Be aware of this study and sign informed consent;
Exclusion criteria
Exclusion criteria: 1.A history of allergic reactions to narcotics; 2.The heart, lungs, liver, kidneys and other important organs are severely dysfunctional; 3.There are serious diseases of the central or peripheral nervous system, diseases of the blood system or coagulation dysfunction, and diseases of the endocrine system; 4.Uncontrolled severe hypertension (systolic pressure greater than or equal to 180mmHg, diastolic pressure greater than or equal to 110mmHg) and malignant arrhythmias; 5.The puncture site is infected; 6.History of mental illness, inability to complete VAS and NRS pain scores; 7.Long-term or recent use of opioid sedatives and analgesics; 8.Refuse to use the pain pump;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Comfort score;PCA degree;First PCA time; | — |
Countries
China
Contacts
Public ContactLian Xiaoqiang
Second Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed